Exploring the in situ evolution of nitrofurantoin resistance in clinically derived uropathogenic Escherichia coli isolates

BACKGROUND: Nitrofurantoin has been re-introduced as a first-choice antibiotic to treat uncomplicated acute urinary tract infections in England and Wales. Highly effective against common uropathogens such as Escherichia coli, its use is accompanied by a low incidence (<10%) of antimicrobial resis...

Descripción completa

Detalles Bibliográficos
Autores principales: Vallée, Maxime, Harding, Chris, Hall, Judith, Aldridge, Phillip D, TAN, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890214/
https://www.ncbi.nlm.nih.gov/pubmed/36480295
http://dx.doi.org/10.1093/jac/dkac398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890214/
https://www.ncbi.nlm.nih.gov/pubmed/36480295
http://dx.doi.org/10.1093/jac/dkac398

Ejemplares similares